Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma (Paperback, Softcover reprint of the original 1st ed. 2012)

This book describes both the technologies used in the discovery of melanoma biomarkers and the clinical application of these biomarkers for diagnosis and staging of disease, determination of prognosis, treatment planning, monitoring of response to therapy, identification of novel therapeutic targets and drug development. A broad range of biomarkers (DNA/chromosomal, mRNA, microRNA, mitochondrial DNA, epigenetic and protein) is outlined. As therapies for melanoma become increasingly more target specific, the identification, validation and use of biomarkers will invariably play a greater role in the management of patients with this disease. Diagnostic and Prognostic Biomarkers and Therapeutic Targets in Melanoma is an essential resource for oncologists, dermatologists, dermatopathologists, general pathologists with an interest in melanoma, and melanoma researchers.

General

Imprint:	HumanaPress
Country of origin:	United States
Series:	Current Clinical Pathology
Release date:	August 2016
First published:	2012
Editors:	Michael J. Murphy
Dimensions:	254 x 178mm (L x W)
Format:	Paperback
Pages:	322
Edition:	Softcover reprint of the original 1st ed. 2012
ISBN-13:	978-1-4939-6186-3
Categories:	Books > Medicine > Clinical & internal medicine > Dermatology Books > Medicine > Other branches of medicine > Pathology > Gross pathology Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > General
LSN:	1-4939-6186-1
Barcode:	9781493961863

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!